111 related articles for article (PubMed ID: 2658742)
21. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
[TBL] [Abstract][Full Text] [Related]
22. BCR/ABL signal transduction.
Tauchi T; Broxmeyer HE
Int J Hematol; 1995 Apr; 61(3):105-12. PubMed ID: 7599321
[TBL] [Abstract][Full Text] [Related]
23. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
[TBL] [Abstract][Full Text] [Related]
24. Possible evidence for acquired genetic activity at both chromosomal breakpoints of the Philadelphia translocation in chronic myeloid leukemia.
Yamada T; Secker-Walker LM
Leukemia; 1990 May; 4(5):341-4. PubMed ID: 2388479
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of chronic myelogenous leukaemia.
Ankathil R; Nair MK
Natl Med J India; 1992; 5(5):219-22. PubMed ID: 1302582
[TBL] [Abstract][Full Text] [Related]
26. [Detection of bcr/abl gene expression on bone marrow cell colonies in chronic myelogenous leukemia by reverse transcriptase-polymerase chain reaction].
Luo Z; Chen H; Luo S; Tang L; Wang J
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):418-20. PubMed ID: 12080671
[TBL] [Abstract][Full Text] [Related]
27. Molecular biology of the Philadelphia positive leukaemias.
Morgan GJ; Wiedemann LM
Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
[TBL] [Abstract][Full Text] [Related]
28. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
Valiente A; Outeriño J; Martín Calderín F; Benítez J
Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
[TBL] [Abstract][Full Text] [Related]
29. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
[TBL] [Abstract][Full Text] [Related]
30. The molecular biology of CML: a review.
Leibowitz D; Young KS
Cancer Invest; 1989; 7(2):195-203. PubMed ID: 2676087
[TBL] [Abstract][Full Text] [Related]
31. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
32. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
Szabo P; Macera MJ; Verma RS
Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
[TBL] [Abstract][Full Text] [Related]
33. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
[TBL] [Abstract][Full Text] [Related]
34. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
[TBL] [Abstract][Full Text] [Related]
35. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.
Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W
Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058
[TBL] [Abstract][Full Text] [Related]
36. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
[TBL] [Abstract][Full Text] [Related]
37. Chronic myelogenous leukemia as a model for the genetic basis of cancer.
Cannistra SA
Hematol Oncol Clin North Am; 1990 Apr; 4(2):337-57. PubMed ID: 2182595
[TBL] [Abstract][Full Text] [Related]
38. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
[No Abstract] [Full Text] [Related]
39. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
40. The Philadelphia translocation in CML and ALL: recent investigations, new detection methods.
Hagemeijer A; van der Plas DC; Soekarman D; van Denderen J; Grosveld G
Nouv Rev Fr Hematol (1978); 1990; 32(1):83-6. PubMed ID: 2190182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]